News

This Friday, Nov. 14th, from 9 am to 1:30 p.m., the Weill Department of Medicine will host its 10th annual Research Retreat Day.

Organized by Dr. Myles Wolf, Chair, Dr. Kyu Rhee, Professor and Vice Chair of Research, and Dr. Gregory Sonnenberg, Professor and Associate Vice Chair of Research, this highly collaborative event will bring together a diverse range of established and emerging faculty, trainees, and experts in complementary fields to foster and expand the Department's research...

Neurons in the gut produce a molecule that plays a pivotal role in shaping the gut’s immune response during and after inflammation, according to a new study by Weill Cornell Medicine investigators. The findings suggest that targeting these neurons and the molecules they produce could open the door to new treatments for inflammatory bowel disease and other disorders driven by gut inflammation.

Hundreds of millions of neurons make up the enteric nervous system, the “second brain” of the...

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.

The study, published Sept. 3 in JAMA Network Open, found that older adults living in flood-hit areas in New Jersey faced a 5% higher risk of heart disease for up to five years after Sandy’s landfall. This is one of the first studies to rigorously quantify long...

The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in the U.S. to use a genetically engineered pig liver to support patients with severe liver failure who don’t qualify for a transplant, according to an American Journal of Transplantation (AJT) report published in August.

“We’ve waited over two decades since the last trial of a bioartificial liver device,” says Dr. Robert Brown,  Chief of the Division of Gastroenterology and Hepatology and a leading...